The stable or transient knockdown of CD271 in melanoma cells revealed that the NCSC-like phenotype is maintained by expression of CD271 (Figure 1d) which in turn controls the levels of downstream targets, e.g., SOX10, FOXD3, and SOX2 (Figure S1c, not shown) [12,40,52]. This evidence concerns the gene SOX2 and melanoma.